Novartis announces that its lung cancer drug, Zykadia, gained European Union approval.
News Update
Advertisement
Articles by News Update
Advertisement
Latest Updated Articles
- Novartis Announces EU Approval of Lung Cancer Drug
Published: May 8th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
